期刊文献+

重组人干扰素α2b的制备研究 被引量:6

Study on the Preparation of Recombinant Human Interferon α2b
下载PDF
导出
摘要 为了获得高活性高纯度的rh IFNα2b,对重组人干扰素α2b进行克隆、表达,并深入研究了其纯化工艺。采用重叠延伸PCR法合成了编码IFNα2b的基因,用DNA重组技术构建了原核表达载体p BV220-IFNα2b,获得了稳定的工程菌种。发酵产物通过破菌、洗涤获得包涵体,再经过变性、复性、离子交换层析和凝胶过滤层析的纯化,得到rh IFNα2b纯品,其比活可达1×10^8IU/mg。实验结果为进一步开展临床前研究和长效制剂奠定了基础。 Recombinant human interferon α2b was prepared by cloning,expression,purification for obtaining rh IFN α2b with high activity and purity. Overlap extension PCR was performed to obtain the gene encoding for IFN α2b. A prokaryotic vector expressing rh IFN α2b was constructed successfully. The expression vector p BV220-IFN α2b was transformed into E. coli strain DH5α. After fermentation,the bacteria cells was collected and lysed. Finally,the rh IFN α2b was purified by denaturation,renaturation,ion exchange chromatography and gel filtration chromatography,and its specific activity reached 1×10^8IU / mg. The results was expected to lay the foundation for preclinical research and long-acting preparation.
出处 《生物技术进展》 2016年第3期212-218,共7页 Current Biotechnology
关键词 干扰素Α2B 制备 表达 纯品 interferon α2b preparation expressing purify
  • 相关文献

参考文献8

  • 1吴玉厚,吴冰洁,周国利,张永忠,傅崇罗,康新江.干扰素研究进展[J].生物学教学,2007,32(7):2-4. 被引量:20
  • 2侯相山,王洪水.干扰素研究进展[J].安徽农业科学,2007,35(6):1700-1702. 被引量:9
  • 3何诚.干扰素的分子生物学研究进展[J].国外医学(微生物学分册),1994,17(4):145-147. 被引量:4
  • 4Leigh J W, Paul P T, Mark R W, et al.. Zinc mediated dimer of human interferon α2b revealed by X-ray crystallography Ra- maswamy[J]. Structure, 1996, 4(12):1153-1163.
  • 5Bruno R, Sacchi P, Cima S, et al.. Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles [J]. J. Viral. Hepat., 2012,19 (1): 33-36.
  • 6魏开坤,马学军,张丽兰,等.人a2b型干扰素的基因合成、表达质粒构建及产物的制法[P].中国,99125966.1,2001.
  • 7萨姆布鲁克 J,拉塞尔 D W 著,黄培堂等译.分子克隆实验指南(第三版)[M].北京:科学出版社,2002
  • 8韩霭辰,王劲峰.疏水相互作用层析分离重组人干扰素α2b[J].微生物学免疫学进展,2012,40(6):8-12. 被引量:2

二级参考文献34

  • 1赵荣志,刘永东,王芳薇,李京京,夏新,苏志国.疏水层析分离正确折叠与错误折叠的复合干扰素[J].生物工程学报,2005,21(3):451-455. 被引量:2
  • 2吴玉厚,吴冰洁,周国利,张永忠,傅崇罗,康新江.干扰素研究进展[J].生物学教学,2007,32(7):2-4. 被引量:20
  • 3龚国忠 郑宣鹤 等.Ib型丙肝病毒在外周血单核细胞感染状态及其对IFN应答的影响[J].中华微生物和免疫,1998,18(6):452-454.
  • 4杨华.猪白细胞干扰素治疗小鹅瘟效果观察[J].中国兽医杂志,2000,(2):54-54.
  • 5XU DZ,HUANG K L,ZHAO K,et al.Vaccination with recombinant HBsAg-HBIG complex in healthy adults[J].Vaccine,2005,23(20):2658-2664.
  • 6杜念兴.兽医免疫学[M].2版.北京:中国农业出版社,2000:75-76.
  • 7KEATING G M,PLOSKER G L.Peginterferon alpha-2a(40 kD) plus ribavirin:a review of its use in the management of patients with chronic hepatitis C and persistently ‘normal' ALT levels[J].Drugs,2005,65(4):5211.
  • 8PATRICK MARCELLIN,GEORGE K K LAU,FERRUCCIO BONINO,et al.Peginterferon alfa-2a alone,lamivudine alone,and the two in combination in patients with HBeAg-Negative chronic hepatitis B[J].N Engl J Med,2004,351(12):12061.
  • 9杨汉春.动物免疫学[M].2版:北京:中国农业出版社,2004:98.
  • 10MARELLI A,NARDECCHIA L,DEGENNARO F,et al.Therapy of chronic hepatitis C with alphar interferon in 182 patients.evaluation of results,response predictive factors and side effects[J].Minerva Med,1999,90(11/12):405-412.

共引文献62

同被引文献57

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部